Status:
COMPLETED
Feasibility Assessment of Risk Stratification and Oral Challenge in Hospitalized Children at Low Risk for Antibiotic Allergy
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Penicillin Allergy
Eligibility:
All Genders
Brief Summary
Children are often reported to have antibiotics allergies, with approximately 10% of the US population labeled as allergic to an antibiotic. Recent studies have demonstrated that a large majority of c...
Eligibility Criteria
Inclusion
- Patients admitted to Vanderbilt children's hospital admitted to a Pediatric Hospital Medicine service with a penicillin allergy reported in their chart who are medically stable
Exclusion
- Known pregnancy
- Patients without a primary care provider
Key Trial Info
Start Date :
September 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 29 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04441021
Start Date
September 15 2020
End Date
June 29 2021
Last Update
June 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232